European private equity firm, Cinven, today announces the completion of its acquisition of CeramTec, the leading global manufacturer of high performance ceramics for application in medical, automotive, industrials and electronic end-markets, for a total consideration of €1.49 billion.
 
Cinven has also completed a successful financing of CeramTec comprising both high yield bonds and loans denominated in euros and US dollars.  The company attracted strong investor demand due to its strong financial performance, as well as the combination of its fast growing and highly profitable medical products and its stable and highly diverse industrial products.

Deutsche Bank, RBC Capital Markets and UBS arranged the financing.